Medpace Holdings (MEDP) Capital Expenditures (2015 - 2026)

Medpace Holdings (MEDP) has reported Capital Expenditures for 12 consecutive years, with $6.8 million the latest figure, recorded in Q1 2026.

• Capital Expenditures for Q1 2026 came in at $6.8 million, down 31.82% year-over-year; the trailing twelve-month figure through Mar 2026 was $28.2 million (down 31.35% YoY), and the FY2025 annual result was $31.4 million, down 14.21% from the prior year.
• Capital Expenditures was $6.8 million for Q1 2026 at Medpace Holdings, up from $4.5 million in the prior quarter.
• Over five years, Capital Expenditures peaked at $12.9 million in Q2 2024 and troughed at $4.5 million in Q4 2025.
• Average Capital Expenditures over 5 years is $8.7 million, with a median of $9.2 million recorded in 2022.
• Year-over-year, Capital Expenditures soared 86.42% in 2022 and tumbled 52.51% in 2025.
• Over 5 years, Capital Expenditures stood at $9.2 million in 2022, then climbed by 8.04% to $10.0 million in 2023, then fell by 23.46% to $7.6 million in 2024, then sank by 40.65% to $4.5 million in 2025, then jumped by 50.22% to $6.8 million in 2026.
• Per Business Quant data, the three most recent Capital Expenditures figures were $6.8 million in Q1 2026, $4.5 million in Q4 2025, and $10.7 million in Q3 2025.